Congress Proposes Medicare Coverage for New Blood Tests to Detect Early Alzheimer's
ASAP Act
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
Impact Analysis
Personal Impact
Milestones
What Happens Next
Projected impacts based on AI analysis
Related News
5 articlesIt’s time for bold action on neurodegenerative diseases
The article advocates for the bipartisan Alzheimer's Screening and Prevention (ASAP) Act, noting it would create a pathway for Medicare to cover FDA-approved blood-based tests for early dementia detection, empowering personal choice and responsibility in brain health.
Vern Buchanan Pushes 'ASAP Act' Expanding Alzheimer's Screening
Florida Congressman Vern Buchanan and Rep. Paul Tonko introduced the ASAP Act to ensure seniors have timely access to innovative diagnostic tests. The bill aims to modernize Medicare's process for covering FDA-approved blood-based tests for early Alzheimer's detection.
ASAP Act Would Expand Alzheimer's Detection
The Alzheimer's Screening and Prevention Act (ASAP) reflects growing recognition that early detection is essential. The bill would empower the HHS Secretary to give Medicare beneficiaries access to FDA-cleared biomarker tests, removing current legislative barriers to preventive services.
Related Bills
1 billSource Information
Analysis generated by AI. Always verify with official sources.